Strategic Diagnostics and Fred Hutchinson Ink Biomarker Discovery Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Strategic Diagnostics and the Fred Hutchinson Cancer Center said yesterday that they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.

Under the collaboration, which will initially focus on pancreatic cancer, Newark, NJ-based SDI will provide approximately 1,000 of its cancer antigen antibodies to Paul Lampe, full member and associate program head of the Molecular Diagnostics Program at Seattle's Hutchinson Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.